Clinical Trial 43433

Oakland, CA 94607


The objective of this study is to assess the safety and efficacy of 3 different doses of CTP-692 administered once daily for 12 weeks to adult patients with schizophrenia on stable dopaminergic antipsychotic medication.

Inclusion Criteria:

  • Physician confirmed DSM-V diagnosis of schizophrenia for the past 2 years
  • Patients with clinically stable schizophrenia with residual symptoms defined as PANSS total score of 70-110
  • Patients currently treated with one antipsychotic medication

Qualified Participants May Receive:

Monetary compensation and study-related care at no cost to the participant

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.